Literature DB >> 16687487

Glucose withdrawal induces oxidative stress followed by apoptosis in glioblastoma cells but not in normal human astrocytes.

Nannette Jelluma1, Xiaodong Yang, David Stokoe, Gerard I Evan, Tobias B Dansen, Daphne A Haas-Kogan.   

Abstract

Tumor cells rely preferentially on anaerobic glycolysis rather than on respiration for ATP generation, a phenomenon known as the Warburg effect. We explored the effects of glucose withdrawal on glioblastoma multiforme-derived cell lines and their nontransformed counterparts, normal human astrocytes. We found that glucose withdrawal induces extensive apoptosis in glioblastoma multiforme cells but not in normal astrocytes. In all cells examined, ATP levels are sustained on glucose withdrawal due to elevation of fatty acid oxidation and ensuing respiration; however, we show that oxidative stress generated in the mitochondrial respiratory chain is the direct cause of cell death in glioblastoma multiforme cells. Oxidative stress that only occurs in glioblastoma multiforme cells underlies the selective susceptibility to glucose withdrawal-induced apoptosis documented in the malignant cells. This study implicates glycolysis as a potentially efficient and selective target for glioblastoma multiforme treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16687487     DOI: 10.1158/1541-7786.MCR-05-0061

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  66 in total

1.  Imaging intracellular pH in live cells with a genetically encoded red fluorescent protein sensor.

Authors:  Mathew Tantama; Yin Pun Hung; Gary Yellen
Journal:  J Am Chem Soc       Date:  2011-06-09       Impact factor: 15.419

2.  Bromopyruvate mediates autophagy and cardiolipin degradation to monolyso-cardiolipin in GL15 glioblastoma cells.

Authors:  Magdalena Davidescu; Miriam Sciaccaluga; Lara Macchioni; Roberto Angelini; Patrizia Lopalco; Maria Grazia Rambotti; Rita Roberti; Angela Corcelli; Emilia Castigli; Lanfranco Corazzi
Journal:  J Bioenerg Biomembr       Date:  2012-02-09       Impact factor: 2.945

3.  MUC1 oncoprotein promotes autophagy in a survival response to glucose deprivation.

Authors:  Li Yin; Surender Kharbanda; Donald Kufe
Journal:  Int J Oncol       Date:  2009-06       Impact factor: 5.650

Review 4.  Manipulation of Glucose and Hydroperoxide Metabolism to Improve Radiation Response.

Authors:  John M Floberg; Julie K Schwarz
Journal:  Semin Radiat Oncol       Date:  2019-01       Impact factor: 5.934

Review 5.  Emerging Approaches for Targeting Metabolic Vulnerabilities in Malignant Glioma.

Authors:  Peter M Clark; Wilson X Mai; Timothy F Cloughesy; David A Nathanson
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

Review 6.  PI3K signaling in glioma--animal models and therapeutic challenges.

Authors:  Christine K Cheng; Qi-Wen Fan; William A Weiss
Journal:  Brain Pathol       Date:  2009-01       Impact factor: 6.508

7.  Akt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition.

Authors:  Yongjun Fan; Kathleen G Dickman; Wei-Xing Zong
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

8.  Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme.

Authors:  Arnulf Mayer; Peter Vaupel; Hans-Garlich Struss; Alf Giese; Marcus Stockinger; Heinz Schmidberger
Journal:  Strahlenther Onkol       Date:  2014-06-18       Impact factor: 3.621

Review 9.  Redox-directed cancer therapeutics: molecular mechanisms and opportunities.

Authors:  Georg T Wondrak
Journal:  Antioxid Redox Signal       Date:  2009-12       Impact factor: 8.401

10.  Metformin influences progression in diabetic glioblastoma patients.

Authors:  Sebastian Adeberg; Denise Bernhardt; Semi Ben Harrabi; Tilman Bostel; Angela Mohr; Christian Koelsche; Christian Diehl; Stefan Rieken; Juergen Debus
Journal:  Strahlenther Onkol       Date:  2015-09-02       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.